Patrick Magill

832 total citations
12 papers, 673 citations indexed

About

Patrick Magill is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Patrick Magill has authored 12 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Patrick Magill's work include HER2/EGFR in Cancer Research (6 papers), Cancer Treatment and Pharmacology (4 papers) and Advanced Breast Cancer Therapies (3 papers). Patrick Magill is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Cancer Treatment and Pharmacology (4 papers) and Advanced Breast Cancer Therapies (3 papers). Patrick Magill collaborates with scholars based in United Kingdom, United States and Taiwan. Patrick Magill's co-authors include Janine Salter, Mitch Dowsett, Simone Detre, José Mayordomo, Antonio Llombart‐Cussac, Geraldine Walsh, Ian E. Smith, Anthony Skene, Emma Clark and Massimo Cristofanilli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Patrick Magill

12 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Magill United Kingdom	10	481	349	196	193	181	12	673
Donald I. Twito United States	11	362 0.8×	233 0.7×	175 0.9×	122 0.6×	170 0.9×	13	603
Catherine Harper‐Wynne United Kingdom	13	549 1.1×	264 0.8×	381 1.9×	183 0.9×	360 2.0×	45	876
Oliver Young United Kingdom	10	351 0.7×	106 0.3×	311 1.6×	145 0.8×	298 1.6×	17	578
Federico Castiglione Italy	8	333 0.7×	142 0.4×	70 0.4×	100 0.5×	138 0.8×	12	465
V. Papadimitrakopoulou United States	13	313 0.7×	304 0.9×	38 0.2×	223 1.2×	110 0.6×	41	606
健二郎青儀	2	404 0.8×	87 0.2×	169 0.9×	83 0.4×	354 2.0×	2	581
C. Brady United States	5	384 0.8×	139 0.4×	257 1.3×	102 0.5×	209 1.2×	6	556
Mauro Porpiglia Italy	11	456 0.9×	124 0.4×	564 2.9×	97 0.5×	449 2.5×	27	813
Mary E. Rothstein United States	8	284 0.6×	204 0.6×	110 0.6×	251 1.3×	77 0.4×	10	537
Toru Hanamura Japan	14	203 0.4×	121 0.3×	197 1.0×	151 0.8×	106 0.6×	38	500

Countries citing papers authored by Patrick Magill

Since Specialization

Citations

This map shows the geographic impact of Patrick Magill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Magill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Magill more than expected).

Fields of papers citing papers by Patrick Magill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Magill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Magill. The network helps show where Patrick Magill may publish in the future.

Co-authorship network of co-authors of Patrick Magill

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Magill. A scholar is included among the top collaborators of Patrick Magill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Magill. Patrick Magill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Thongprasert, Sumitra, Emma Duffield, Nagahiro Saijo, et al.. (2011). Health-Related Quality-of-Life in a Randomized Phase III First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients from Asia with Advanced NSCLC (IPASS). Journal of Thoracic Oncology. 6(11). 1872–1880. 107 indexed citations

Osborne, C. Kent, Patrick Neven, Luc Dirix, et al.. (2011). Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II Study. Clinical Cancer Research. 17(5). 1147–1159. 138 indexed citations

Cristofanilli, Massimo, Vicente Valero, Aroop Mangalik, et al.. (2010). Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer. Clinical Cancer Research. 16(6). 1904–1914. 134 indexed citations

Valero, Vicente, Sarah Bacus, A Mangalik, et al.. (2009). Molecular marker correlates of clinical outcome in a phase II study of gefitinib or placebo in combination with anastrozole in postmenopausal women with hormone receptor-positive metastatic breast cancer.. Cancer Research. 69(2_Supplement). 3131–3131. 4 indexed citations

Cristofanilli, Massimo, V. Valero, A Mangalik, et al.. (2008). A phase II multicenter, double-blind, randomized trial to compare anastrozole plus gefinitib with anastrozole plus placebo in postmenopausal women with hormone receptor-positive (HR+) metastatic breast cancer (MBC). Journal of Clinical Oncology. 26(15_suppl). 1012–1012. 39 indexed citations

Smith, Ian E., Geraldine Walsh, Anthony Skene, et al.. (2007). A Phase II Placebo-Controlled Trial of Neoadjuvant Anastrozole Alone or With Gefitinib in Early Breast Cancer. Journal of Clinical Oncology. 25(25). 3816–3822. 169 indexed citations

Kennedy, Stephen, Xu Yu Jin, Patrick Magill, et al.. (2006). Randomized controlled trial assessing a traditional Chinese medicine remedy in the treatment of primary dysmenorrhea. Fertility and Sterility. 86(3). 762–764. 13 indexed citations

Dowsett, Mitch, I. E. Smith, A. Skene, et al.. (2006). Biological and clinical outcomes from a phase II placebo-controlled neoadjuvant study of anastrozole alone or with gefitinib in postmenopausal women with ER/PgR+ breast cancer (Study 223). Journal of Clinical Oncology. 24(18_suppl). 515–515. 17 indexed citations

MacKenzie, I.Z., Patrick Magill, & Ethel Burns. (1997). Randomised trial of one versus two doses of prostaglandin E₂ for induction of labour: 2. Analysis of cost. BJOG An International Journal of Obstetrics & Gynaecology. 104(9). 1068–1072. 15 indexed citations

10.

Waxman, Jonathan, J. Sandow, A. Man, et al.. (1986). The first clinical use of depot buserelin for advanced prostatic carcinoma. Cancer Chemotherapy and Pharmacology. 18(2). 174–5. 12 indexed citations

11.

Kennedy, T, Patrick Magill, G W Johnston, & T G Parks. (1979). Proximal gastric vagotomy, fundoplication, and lesser-curve necrosis.. BMJ. 1(6176). 1455–1456. 21 indexed citations

12.

Evans, Robert & Patrick Magill. (1974). Evidence for mutation being the source of the abnormal gene for plasma cholinesterase. Journal of Medical Genetics. 11(2). 117–120. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact